LRCX LAM RESEARCH CORP Insider Trading

SVP Neil J Fernandes sold 7,659 shares of LRCX at $309.60 (total $2.4M); post-sale holdings 58.5K shares under 10b5-1 plan.

Neil J Fernandes executed a scheduled sale of 7,659 shares under a 10b5-1 trading plan adopted on 2025-11-17, reducing his LRCX holdings by -11.6% to 58.5K shares. The stock traded at $309.60 on 2026-06-01 and currently sits at $332.22, near its 52-week high of $333.33. His prior LRCX sales on 2026-05-01 and 2024-07-12 show divergent outcomes: the May 2026 sale saw subsequent price appreciation (+24.7% in 30 days), while the July 2024 and June 2024 sales preceded sharp declines of -92.4% and -91.5% respectively. As a pre-arranged transaction, the timing reflects the plan's schedule rather than discretionary market judgment.

SVP Neil Fernandes sells ~$4.6M in LAM shares, trimming position by over one-fifth at elevated valuation.

Neil Fernandes, a Senior Vice President at LAM Research, sold roughly one-fifth of his shareholdings in a single transaction, raising approximately $4.6 million. The sale occurred when the stock was trading near the middle of its recent range—down slightly from all-time highs but still benefiting from strong momentum over recent months. As a C-suite officer with direct operational insight into the company, his decision to trim a substantial block of shares warrants attention, particularly given that the company's financial position remains strong with healthy profitability and growing revenue. However, the sale is not dramatic enough to suggest panic; rather, it appears consistent with a disciplined officer rebalancing a concentrated position or taking gains after a period of appreciation. The timing and size merit observation, though this is not uncommon for senior executives managing their personal wealth after periods of strong stock performance.